Stay updated with breaking news from Nasdaq Allo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Free Report) reached a new 52-week low during mid-day trading on Thursday . The company traded as low as $2.88 and last traded at $3.03, with a volume of 486164 shares changing hands. The stock had previously closed at $3.08. Analysts Set New Price Targets A number of brokerages […]
Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Free Report)’s stock price reached a new 52-week low during mid-day trading on Wednesday . The company traded as low as $2.88 and last traded at $3.00, with a volume of 1531650 shares traded. The stock had previously closed at $3.16. Analyst Ratings Changes ALLO has been the topic […]
Shares of Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Free Report) have earned an average recommendation of “Moderate Buy” from the eleven analysts that are covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, two have given a hold recommendation and eight have assigned a buy recommendation to the company. […]
Allogene Therapeutics (NASDAQ:ALLO – Free Report) had its target price cut by JPMorgan Chase & Co. from $11.00 to $9.00 in a research report sent to investors on Monday morning, Marketbeat.com reports. They currently have an overweight rating on the stock. ALLO has been the subject of a number of other research reports. Oppenheimer reaffirmed […]
Shares of Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the twelve ratings firms that are covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and nine have given a buy recommendation […]